Dr. Martha McCollough, MD
What this data tells you about Dr. McCollough
Dr. Martha McCollough is a dermatology specialist in Tyler, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. McCollough performed 15,881 Medicare services across 10,383 unique beneficiaries.
Between the years covered by Open Payments, Dr. McCollough received a total of $9,728 from 33 pharmaceutical and/or device companies across 412 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McCollough is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tissue pathology examination, moderate complexity | 10,094 | $52 | $235 |
| Destruction of precancerous skin growths, 2-14 | 1,608 | $5 | $23 |
| Office visit, established patient (20-29 min) | 1,035 | $58 | $297 |
| Pathology examination of tissue using a microscope, moderately low complexity | 583 | $30 | $141 |
| Destruction of precancerous skin growth, 1 | 450 | $40 | $223 |
| Special stained specimen slides to identify organisms including interpretation and report | 411 | $83 | $371 |
| Tissue staining for diagnosis, initial | 392 | $74 | $329 |
| Tissue staining for diagnosis, additional | 321 | $64 | $280 |
| Skin biopsy, tangential | 206 | $70 | $338 |
| Steroid injection (triamcinolone) | 174 | $1 | $24 |
| Antibody evaluation, each additional single antibody stain procedure | 115 | $91 | $385 |
| Biopsy of related skin growth, each additional growth | 70 | $39 | $168 |
| New patient office visit (30-44 min) | 62 | $63 | $369 |
| Office visit, established patient (10-19 min) | 51 | $35 | $186 |
| Office visit, established patient (30-39 min) | 50 | $85 | $420 |
| Destruction of precancer skin growth, 15 or more growths | 43 | $117 | $562 |
| Pathology examination of tissue using a microscope, limited examination | 41 | $12 | $54 |
| Destruction of skin growths (warts/lesions), 1-14 | 38 | $86 | $378 |
| Special stained specimen slides to examine tissue including interpretation and report | 37 | $59 | $271 |
| Drug injection, under skin or into muscle | 26 | $9 | $47 |
| Pathology examination of specimen during surgery, first tissue block | 23 | $73 | $336 |
| Antibody evaluation, initial single antibody stain procedure | 23 | $118 | $502 |
| Blood draw (venipuncture) | 15 | $8 | $10 |
| Biopsy of ear | 13 | $62 | $321 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
6.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. McCollough is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. McCollough experienced with tissue pathology examination, moderate complexity?
Does Dr. McCollough receive payments from pharmaceutical companies?
How do Dr. McCollough's costs compare to other dermatologists in Tyler?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology